The Latest Breaking News from Autoimmune Disease

The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending conditional approval for Calliditas Therapeutics AB's (NASDAQ:CALT) Kinpeygo for primary immunoglobulin A (IgA) nephropathy (IgAN). The opinion covers adult patients at risk of rapid disease progression with a urine protein-to-creatinine ratio (UPCR) ≥1.5 g/gram.  Also See: Calliditas…

From stress to sunlight to hormones, here are five common factors that can contribute to a flare-up of Lupus symptoms.

A UK CHAIRTY is urging the public to join efforts to raise awareness of an incurable autoimmune disease as World Lupus Day is marked.

The European Commission has approved Horizon Therapeutics plc's (NASDAQ:HZNP) Uplizna (inebilizumab) as monotherapy for neuromyelitis optica spectrum disorder (NMOSD) who are anti-aquaporin-4 immunoglobulin G seropositive (AQP4-IgG+). NMOSD is an autoimmune disease that attacks the optic nerve, spinal cord, brain, and brain stem. In the N-MOmentum pivotal clinical trial, Uplizna demonstrated a significant reduction…

Lupus is a long-term condition that causes joint pain and skin rashes and has no cure.

The autoimmune disease lupus had ruined my life until I landed an interview at the Southbank Centre. After years of trying to fit in I’d found my tribe – and a way to get better

NEW DELHI: In the last few months, AIIMS has come across at least 30 patients who developed symptoms associated with autoimmune diseases such as rheumatoid arthritis and Sjogren’s syndrome within weeks of getting Covid-19.